StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
ADVBAdvanced Biomed Inc.
stockpulse.co.kr
Nasdaq
$3.11▼ 7.16%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $5.1MShares out 1.6M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

6
  • 10.13After-hours26.10.14 05:16
    10-KEarnings#●●●#●●●

    Advanced Biomed Inc.

    Advanced Biomed Inc. effected a 1-for-20 reverse stock split on February 20, 2026. As of October 13, 2026, the company had 1,652,133 shares of common stock outstanding and completed the acquisition of Acellent Technologies (Hong Kong) Co. Limited as a wholly owned subsidiary on April 30, 2026.…more

    $3.11-7.16%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 9.28After-hours26.09.29 05:30
    NT 10-KEarnings

    Advanced Biomed Inc.

    Advanced Biomed Inc. has delayed the filing of its Form 10-K annual report for the fiscal year ended June 30, 2026, due to the incomplete audit of its financial statements. The company expects to file the report within the prescribed extension period.…more

    $3.11-7.16%vs prev close
    View filingShare
  • 9.22Pre-market26.09.22 20:54
    SCHEDULE 13GOwnership

    Advanced Biomed Inc.

    Advance On Ventures Limited and Chen Yi Lee have jointly filed a Schedule 13G regarding their holdings in Advanced Biomed Inc. This filing serves as a formal joint filing agreement to report their ownership status of the company's common stock.…more

    $3.11-7.16%vs prev close
    View filingShare

5 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire

No news collected yet. New articles will appear here.